Gilead Sciences (GILD)

Capital Expenditure

-$352.00M

TTM · Period ending: · USD

GILD logo

GILD Capital Expenditure

Latest reported-$352.00M
GILD TTM CapEx (-$6.00M → -$352.00M)
High-resolution chart · PNG

GILD capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-352,000,000
-576,000,000
-563,000,000
-505,000,000
-499,000,000
-522,000,000
-523,000,000
-591,000,000
-572,000,000
-581,000,000
-585,000,000
-551,000,000
-586,000,000
-590,000,000
-728,000,000
-703,000,000
-685,000,000
-661,000,000
-579,000,000
-604,000,000
-620,000,000
-644,000,000
-650,000,000
-672,000,000
-717,000,000
-759,000,000
-825,000,000
-870,000,000
-837,000,000
-949,000,000
-924,000,000
-896,000,000
-858,000,000
-684,000,000
-590,000,000
-539,000,000
-608,000,000
-689,000,000
-748,000,000
-745,000,000
-833,000,000
-800,000,000
-747,000,000
-748,451,000
-597,451,000
-517,451,000
-557,451,000
-459,472,000
-361,652,000
-315,928,000
-190,782,000
-391,181,000
-420,585,000
-412,701,000
-397,046,000
-153,285,000
-150,990,000
-140,233,000
-131,904,000
-129,155,000
-75,672,000
-65,088,000
-61,884,000
-65,510,000
-72,829,000
-77,652,000
-230,057,000
-244,730,000
-258,003,000
-262,327,000
-115,005,000
-92,667,000
-73,765,000
-70,356,000
-78,648,000
-89,539,000
-118,454,000
-115,991,000
-105,208,000
-88,037,000
-57,912,000
-53,334,000
-47,951,000
-57,179,000
-56,792,000
-54,886,000
-51,366,000
-29,096,000
-133,384,000
-125,685,000
-123,000,000
-128,075,000
-17,139,000
-17,237,000
-17,597,000
-22,192,000
-23,563,000
-26,105,000
-26,329,000
-20,705,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.